PRNewsWire
09 Dec 2025, 13:30 UTC · 39w ago
Avant Technologies and Austrianova Advancing α-Klotho Cell Therapy as Mayo Clinic Study Links Low α-Klotho Levels to Poor Cardiovascular Survival
Verdict
Headline takes no side. We score AVAI +0.80.
Our read: bullish.
AVAI score
+0.80
More positive than 88% of ticker scores this week
Price reaction
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Analysis by





